Figure 1. Effect of high glucose on the expression of XBP1S. A: diagram shows the formation of XBP1S from XBP1U mRNA, a 26 bp fragment(from 484 to 509) was deleted during splicing. B: electrophoresis of RT-PCR products indicates MCs expressed both XBP1U and XBP1S. C and D:Western blot and real time PCR result show the expression of XBP1S before and after high glucose treatment (mean 6 SEM, n = 5).E: Western blotresult shows the expression of XBP1U before and after high glucose treatment for 48 h (mean 6 SEM, n = 6) *p,0.05 compared to NG; ***p,0.001compared to NG
Figure 2. Effects of high glucose treatment on collagen IV and fibonectin. Western blot results show high glucose treatment increasescollagen IV (A) and fibronectin (B) levels (mean 6 SEM, n = 6). DPI reverses high glucose-induced increase in collagen IV and fibronectin expressions(C) (mean 6 SEM, n = 5). *p,0.05 compared to NG; ***p,0.001 compared to NG. #p,0.05 compared with HG.
Figure 3. Effects of high glucose on ROS generation and p47phox expression. A and B: Observation of ROS generation by DHE fluorescentprobe assay (mean 6 SEM, n = 7). C: Western blot analysis on p47phox expression (mean 6 SEM, n = 6). ***p,0.001 compared to NG; ###p,0.001compared to HG.
Figure 4. Identification of XBP1S expression after transfection of Ad-GFP or Ad-XBP1S. A: Observation of the cell under fluorescentmicroscope after transfection of Ad-GFP or Ad-XBP1S for 24 h. B: Western blot analysis on XBP1S protein level after Ad-GFP or Ad-XBP1S transfectionfor 48 h.
Figure 5. Western blot analysis on ECM expressions in thecultured MCs with or without Ad-XBP1S transfection for 48 h.A: Collagen IV; B: Fibronectin (mean 6 SEM, n = 5). *p,0.05 comparedto NG; #p,0.05 compared with HG.
Figure 6. Changes in p47 and ROS generation after transfection of Ad-GFP or Ad-XBP1S. A: Western blot analysis on p47phox levels inthe cultured MCs before and after Ad-XBP1S transfection for 48 h (mean 6 SEM, n = 5). B: Observation of ROS generation by DHE fluorescent probeassay in the cultured MCs before and after Ad-XBP1S transfection for 48 h (mean 6 SEM, n = 8). *p,0.05 compared to NG; #p,0.05 compared withHG; ##p,0.01 compared to HG. C: Western blot analysis on collagen IV and fibronectin levels after transfection of Ad-XBP1S or Ad-XBP1S+xanthineand xanthine oxidase (X?XO) for 48 h in the presence of HG. **p,0.01 compared to Ad-GFP; #p,0.05 compared with Ad-XBP1S (mean 6 SEM, n = 5).
Figure 6. Changes in p47 and ROS generation after transfection of Ad-GFP or Ad-XBP1S. A: Western blot analysis on p47phox levels inthe cultured MCs before and after Ad-XBP1S transfection for 48 h (mean 6 SEM, n = 5). B: Observation of ROS generation by DHE fluorescent probeassay in the cultured MCs before and after Ad-XBP1S transfection for 48 h (mean 6 SEM, n = 8). *p,0.05 compared to NG; #p,0.05 compared withHG; ##p,0.01 compared to HG. C: Western blot analysis on collagen IV and fibronectin levels after transfection of Ad-XBP1S or Ad-XBP1S+xanthineand xanthine oxidase (X?XO) for 48 h in the presence of HG. **p,0.01 compared to Ad-GFP; #p,0.05 compared with Ad-XBP1S (mean 6 SEM, n = 5).
In conclusion, in the experiment, we provided the evidence thatXBP1S pathway of ER stress was suppressed in HG-treated renalMCs and renal cortex of diabetic rats. The suppression of XBP1Swas related the NADPH oxidase activity and HG-induce ROSoverproduction and consequent ECM synthesis. How does theHG treatment influence XBP1S pathway and whether XBP1Spathway can be a target modulating HG-induced oxidative stressand renal damage need further investigations.